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ABSTRACT
Fetal macrosomia is an obstetric complication that makes child birth hazardous to women in labor, and sometimes
an enigma to medical practitioners. It tasks the skills of obstetricians and places a burden on human and material 
medical resources. There is therefore a need for the prevention of fetal macrosomia in order to reduce the 
accompanying feto-maternal morbidity and mortality. Though nutritional restriction has been suggested, it seems 
that better preventive strategies need to be developed, since clinical trials have established that low glycemic index 
food do not necessarily reduce incidence of fetal macrosomia in susceptible women. However, quantification of 
food intake and the magnitude of disparity between high and low glycemic index foods administered to control and 
intervention groups, need to be known in order to fully validate the outcome of randomized controlled trial.
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INTRODUCTION
Fetal macrosomia is a condition in which the fetal birth weight is 4000g or more regardless of age. It has been more 
appropriately defined as fetal weight above the 90th percentile for a given gestational age in weeks (Resnik, 2003). 
The criterion for this definition is related to the maximum birth weight of fetus that the human pelvis can effectively 
transport from the uterus to the exterior. This criterion depends on the pelvic size, which varies according to 
geopolitical regions and level of nutrition. 
In a study of 23 countries by Koyanagi et al. (2013), the 90th percentile of birth weight was 3250 g in India and 
4050g in Algeria, while the 90th percentile in United States of America ranged between 4060g and 4500g (Resnik, 
2003).  Therefore, when the fetal weight is above the benchmark for a given geopolitical region, feto-pelvic 
disproportion ‘in breech presenting fetuses (fetus presenting with buttocks) or cephalo-pelvic disproportion ‘in 
cephalic presenting fetuses (fetus presenting with head) occur. Thaddeus and Maine (1994) further emphasized that 
in areas where there is delay in management due to prolonged obstructed labor, fetal and maternal complications 
may occur. Complications include shoulder dystocia and its associated complications of birth asphyxia and brachial 
nerve injury, and maternal trauma such as obstetric fistulae, sepsis, hemorrhage, and obstetric shock secondary to 
ruptured uterus (Resnik, 2003).
It has been suggested that limitation of intake of dietary calories to 2000 Calories (Kilocalories), adequate exercise 
and avoidance of sedentary lifestyle, are capable of preventing obesity, excessive gestational weight gain and 
therefore fetal macrosomia (Inegbenebor and Ebomoyi, 2012). In a randomized controlled trial involving 800 
women at risk of fetal macrosomia in their second pregnancies, a low glycemic index diet in pregnancy did not 
reduce the incidence of ‘large' for gestational age infants. There was however, a significant positive effect on 
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gestational weight gain and maternal glucose intolerance (Walsh et al, 2012). But, quantification of food intake and 
the magnitude of disparity between high and low glycemic index foods administered to control and intervention 
groups need to be known in order to fully validate the outcome of this randomized control trial.
Considering the fetal and maternal health implications of fetal macrosomia, there is therefore a need to develop 
preventive strategies to reduce the incidence of fetal macrosomia and the associated feto-maternal morbidity and 
mortality. This article discusses the possible preventive measures of fetal macrosomia while giving an insight of the 
condition.
DISTRIBUTION OF FETAL MACROSOMIA
Although fetal macrosomia is found in all parts of the world (Dennedy and Dunne, 2013), it is expected that the 
incidence will be higher in affluent countries, where the nutritional status is higher. However, it is also becoming 
increasingly prevalent in developing countries.
Specifically, the prevalence of fetal macrosomia in developed countries has increased by some 15 - 25% in recent 
decades; an increase largely attributed to increasing maternal obesity and diabetes (Koyanagi et al, 2013). The 
prevalence of a birth-weight of 4000g or greater ranging from 0.5% in India (90th percentile, 3250 g) to 14.9% in 
Algeria (90th percentile, 4050g) has been documented (Koyanagi et al, 2013). In the case of Nigeria in particular, an 
analysis of 6376 singleton births in Lagos, presented a 4.9% prevalence of macrosomia and the attending perinatal 
mortality was 58 per 1000 compared to 18 per 1000 in controls (Abudu and Awonuga, 1989).
DETERMINANTS OF FETAL MACROSOMIA
According to Savona-Ventura and Chircop (2004), fetal macrosomia appears to be commoner in the older obese and 
previously diabetic women, who have had at least one previous pregnancy or miscarriage. By implication, factors 
that have been linked to fetal macrosomia include uncontrolled diabetes mellitus, pre-gravid maternal obesity, 
excessive gestational weight gain, as well as maternal over-nutrition. Foods with high glycemic index such as sugary 
beverages, high energy dense carbohydrate diets and fatty diets commonly served in fast food restaurants have been 
suggested as capable of causing fetal macrosomia (Inegbenebor and Ebomoyi, 2012). These causes have a common 
factor of persistent hyperglycemia which is believed to be converted by fetal insulin into adipose tissue and believed 
to induce excessive bone growth especially of the shoulders (Sacks, 2007). Other risk factors for macrosomia 
according to Koyanagi et al. (2013) include; male fetal sex, high parity, maternal age, maternal height and post-term 
pregnancy.
DETERRENTS OF FETAL MACROSOMIA
Fetal macrosomia poses perinatal risks to mother and child. These include prolonged obstructed labor due to feto-
pelvic disproportion or cephalopelvic disproportion (Inegbenebor and Ebomoyi, 2012). There may also be maternal 
trauma such as obstetric fistulae, which are socially devastating to affected women (Koyanagi et al., 2013) and 
postpartum hemorrhage, a frequent cause of maternal mortality. In fact, it is the cause of increased risk of caesarean 
section, prolonged labor, maternal haemorrhage, and perineal trauma (Koyanagi et al., 2013).
Neonatal complications such as shoulder dystocia, neonatal asphyxia, and neonatal injuries such as Erbs palsy and 
klumpke’s palsy (Resnik, 2003) may lead to childhood and adult disability as well as death.
INTERVENTION STRATEGIES FOR PREVENTING FETAL MACROSOMIA
Prevention strategies for fetal macrosomia can be discussed at five levels of intervention as stated by Lucas and 
Gilles (2006) and Park (2007).   
1. Health promotion and education: This involves behavioral modification of susceptible women through 
interpersonal communication, mass media, and folk media. A perusal of the determinants of fetal 
macrosomia presupposes that avoidance of high energy dense, high glycemic index foods (Ihediohanma, 
2011) and beverages can prevent fetal macrosomia in glucose tolerant susceptible women. In view of this 
fact, the suggestion by Inegbenebor and Ebomoyi (2012) becomes relevant. However, a controlled trial 
carried out on 800 women in Ireland disagrees with this suggestion (Walsh et al, 2012). Of interest in the 
study by Walsh et al. (2012) is the reported reduction in gestational weight gain and improved glucose 
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tolerance even though nothing was reported on the quantification and the disparity of the administered diet 
between the control and intervention groups.
2. Specific protection: intra-peritoneal injection of aqueous extract of Alligator pepper (Zingiberaceae 
aframomum melegueta) was found to reduce gestational weight gain and litter size in female Sprague 
Dawley rats without adverse effects on the off springs or mother rats (Inegbenebor et al., 2009). It was 
therefore suggested that further research be done to determine the possibility of use of this extract as a food 
supplement or vaccine in women at risk of fetal macrosomia (Inegbenebor et al., 2009; Inegbenebor and 
Ebomoyi, 2012).
Interestingly, some researchers have found that the extract of Alligator pepper causes improved glucose 
tolerance in normo-glycermic and alloxan induced diabetic rats (Mojekwu et al., 2011). In addition, a 
recent study showed that oral ingestion of alligator pepper extract increased whole body energy expenditure 
through the activation of brown adipose tissue in human subjects (Sugita et al., 2013). Considering the fact 
that brown adipose tissue is preponderant in newborns, this effect might explain the litter size reduction in 
pregnancies treated with intra-peritoneal injection of aqueous extract of Alligator pepper as previously 
reported by Inegbenebor et al. (2009).
There is however a probability that the active ingredient in Alligator pepper might be implicated. Abscicic 
acid, a sesquiterpene isoprenoid phytohormone, that has been shown to be an endogenous stimulator of 
insulin release from human pancreatic β cells with cyclic ADP-ribose as second messenger (Bruzzone et 
al., 2008) might be responsible for the improved glucose tolerance, while, 6-Paradol (6-gingerol) is 
responsible for the energy expenditure secondary to activation of brown adipose tissue as reported by 
Sugita et al. (2013). By implication, abscicic acid and or 6-Paradol may be the principal active constituents
of Alligator pepper that can prevent fetal macrosomia.
3. Early diagnosis and treatment: Early diagnosis can be done with the aid of obstetric ultrasound scan, 
which can estimate fetal weight though with decreasing precision as gestational age increases (Resnik, 
2003). However diagnosis is often retrospective as birth weight can only be measured after delivery of the 
fetus. Active management of labor is the rule in women with fetal macrosomia. Warning signs for obstetric 
intervention include fetal distress, cervical dystocia, and delayed descent. Intervention may be in form of 
induction of labor, cesarean section, or skilled management of shoulder dystocia. Expertise in management 
of post partum hemorrhage that may complicate prolonged labor or induction is also required. 
Neonatologist should be available to manage neonatal asphyxia that may occur.
4. Limitation of disability: Maternal complications such as obstetric fistulae should be referred to the 
gynecologist while foot drop should be referred to the physiotherapist. Fetal complications such as 
fractured clavicle, Erb’s palsy and klumpke’s palsy should be managed by the orthopedic surgeon and 
physiotherapist respectively.
5. Rehabilitation: Where maternal complications are of such magnitude that they result in chronic disability, 
the mothers should be rehabilitated functionally, socially, psychologically and vocationally (Park, 2007), so 
that they live an economically productive life devoid of social ostracism. Children with cerebral palsy can 
be give special education in order to make them socially acceptable and economically productive.
CONCLUSION
Fetal macrosomia is an undesirable condition that can lead to devastating obstetric complications and childhood 
obesity. It tasks the capability and endurance of the obstetrician, consumes the hospital facilities and may cause 
untold suffering to mother and child. It is therefore better prevented. If prevention is ineffective or impossible, 
adequate human and material resources must be available for early diagnosis and treatment, limitation of disability 
and rehabilitation.
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